The way to prevent postoperative detachment ciliochoroidal
(57) Abstract:
Usage: in ophthalmology at the prevention of postoperative ciliochoroidal detachment. The inventive before and after surgery podkonyunktivalno enter contrical 300 Acre, and during the operation it is introduced in the form of instillation. The invention relates to medicine, namely to ophthalmology.Known methods of prevention ciliochoroidal detachment, providing for the introduction under the conjunctiva of the operated eye caffeine, dicynone with oral assignment verospiron and digoxin /1/, podklyuchenie injection of glycerol /3/, emoxipin /4/.Closest to the invention method, based on the use of steroids, Mydriatics, angioprotectors /2/.However, when applying the above method, the rate of postoperative detachment is quite high.Our research found that ciliochoroidal detachment is accompanied by increased activity of lysosomal enzymes /cathepsin D and B) in suprachoroidal fluid and in the serum of patients going on intraocular surgery, compared with the control group patients. Therefore, prevention silizium the cell membrane and prevents the release of enzymes from damaged cells during surgical trauma and prevents the development of retinal vascular sheath.The aim of the invention is to reduce postoperative ciliochoroidal detachment.This goal is achieved by applying podklyucheniya injection kontrikala /300 ATaE/ on the operating table before the surgery, instillaciei working solution kontrikala in breeding 1000 ATpE/ ml of saline solution during surgery and after surgery introduction under the conjunctiva 300 ATpE kontrikala through day N 3-4.Example. The patient-and MT 1928 R. was admitted to the hospital 11.3.93, diagnosed with open-angle 3-4 glaucoma of the left eye, open 1 and glaucoma of the right eye I. B. N 1779/312. 12.3.93 were deep sclerectomy by S. N. Fedorov, on the operating table before the operation under the conjunctiva introduced 300 ATpE /0.3 ml working solution kontrikala in breeding 1000 ATpE/ml saline/ kontrikala. During the operation after iridectomy has istrirovali working solution kontrikala. Then every other day during the week subkonyunktivalno introduced 300 ATpE /0.3 ml/ kontrikala in the amount of 3 injections. The postoperative period was uneventful, detachment of the choroid has not developed.Under the proposed method conducted prevention 21 patient. All pain is observed.Thus, the proposed method is compared with the prototype of the most effective. The way to prevent postoperative ciliochoroidal detachment involving the introduction of anti-inflammatory drugs under the conjunctiva, characterized in that as anti-inflammatory agents use contrical that is administered in the form of a solution before surgery in the amount of 300 Acre during surgery by instillation and after a specific intervention on the 300 Acre during the week through the day.
FIELD: medicine.
SUBSTANCE: method involves introducing 0.1-0.3 ml of photosensitizing gel preliminarily activated with laser radiation, after having removed neovascular membrane. The photosensitizing gel is based on a viscoelastic of hyaluronic acid containing khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-2% by mass. The photosensitizing gel is in vitro activated with laser radiation having wavelength of 661-666 nm during 3-10 min with total radiation dose being equal to 100-600 J/cm2. The gel is introduced immediately after being activated. To compress the retina, vitreous cavity is filled with perfluororganic compound or air to be further substituted with silicon oil. The operation is ended with placing sutures on sclerotomy and conjunctiva areas. Compounds like chealon, viscoate or hyatulon are used as viscoelastic based on hyaluronic acid. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity.
EFFECT: excluded recurrences of surgically removed neovascular membrane and development of proliferative retinopathy and retina detachment; retained vision function.
3 cl, 5 dwg
FIELD: medicine.
SUBSTANCE: method involves introducing 0.1-0.3 ml of photosensitizing gel preliminarily activated with laser radiation, after having removed neovascular membrane. The photosensitizing gel is based on a viscoelastic of hyaluronic acid containing khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-2% by mass. The photosensitizing gel is in vitro activated with laser radiation having wavelength of 661-666 nm during 3-10 min with total radiation dose being equal to 100-600 J/cm2. The gel is introduced immediately after being activated. To compress the retina, vitreous cavity is filled with perfluororganic compound or air to be further substituted with silicon oil. The operation is ended with placing sutures on sclerotomy and conjunctiva areas. Compounds like chealon, viscoate or hyatulon are used as viscoelastic based on hyaluronic acid. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity.
EFFECT: excluded recurrences of surgically removed neovascular membrane and development of proliferative retinopathy and retina detachment; retained vision function.
3 cl, 5 dwg
FIELD: medicine.
SUBSTANCE: method involves introducing 0.1-0.3 ml of photosensitizing gel preliminarily activated with laser radiation, after having removed neovascular membrane. The photosensitizing gel is based on a viscoelastic of hyaluronic acid containing khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-2% by mass. The photosensitizing gel is in vitro activated with laser radiation having wavelength of 661-666 nm during 3-10 min with total radiation dose being equal to 100-600 J/cm2. The gel is introduced immediately after being activated. To compress the retina, vitreous cavity is filled with perfluororganic compound or air to be further substituted with silicon oil. The operation is ended with placing sutures on sclerotomy and conjunctiva areas. Compounds like chealon, viscoate or hyatulon are used as viscoelastic based on hyaluronic acid. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity.
EFFECT: excluded recurrences of surgically removed neovascular membrane and development of proliferative retinopathy and retina detachment; retained vision function.
3 cl, 5 dwg
FIELD: medicine.
SUBSTANCE: method involves introducing hypotensive means by means of instillations. Eye drops of emoxipin are instilled 20-30 min later twice a day during 4-8 weeks. The treatment course is repeated in 2-3 months.
EFFECT: improved vision function; normalized hemodynamic values.
1 tbl
